Abstract:Background: Several (online) adaptive radiotherapy procedures are available to maximize healthy tissue sparing in the presence of inter/intrafractional motion during stereotactic body radiotherapy (SBRT) on an MR-linac. The increased treatment complexity and the motion-delivery interplay during these treatments require MR-compatible motion phantoms with time-resolved dosimeters to validate end-to-end workflows. This is not possible with currently available phantoms. Purpose: Here, we demonstrate a new commercial hybrid film-scintillator cassette, combining high spatial resolution radiochromic film with four time-resolved plastic scintillator dosimeters (PSDs) in an MRI-compatible motion phantom. Methods: First, the PSD's performance for consistency, dose linearity, and pulse repetition frequency (PRF) dependence was evaluated using an RW3 solid water slab phantom. We then demonstrated the MRI4D scintillator cassette's suitability for time-resolved and motion-included quality assurance for adapt-to-shape (ATS), trailing, gating, and multileaf collimator (MLC) tracking adaptations on a 1.5 T MR-linac. To do this, the cassette was inserted into the Quasar MRI4D phantom, which we used statically or programmed with artificial and patient-derived motion. Simultaneously with dose measurements, the beam-gating latency was estimated from the time difference between the target entering/leaving the gating window and the beam-on/off times derived from the time-resolved dose measurements. Results: Experiments revealed excellent detector consistency (standard deviation ≤ $\le$ 0.6%), dose linearity (R2 = 1), and only very low PRF dependence ( ≤ $\le$ 0.4%). The dosimetry cassette demonstrated a near-perfect agreement during an ATS workflow between the time-resolved PSD and treatment planning system (TPS) dose (0%-2%). The high spatial resolution film measurements confirmed this with a 1%/1-mm local gamma pass-rate of 90%. When trailing patient-derived prostate motion for a prostate SBRT delivery, the time-resolved cassette measurements demonstrated how trailing mitigated the motion-induced dose reductions from 1%-17% to 1%-2% compared to TPS dose. The cassette's simultaneously measured spatial dose distribution highlighted the dosimetric gain of trailing by improving the 3%/3-mm local gamma pass-rates from 80% to 97% compared to the static dose. Similarly, the cassette demonstrated the benefit of real-time adaptations when compensating patient-derived respiratory motion by showing how the TPS dose was restored from 2%-56% to 0%-12% (gating) and 1%-26% to 1%-7% (MLC tracking) differences. Larger differences are explainable by TPS-PSD coregistration uncertainty combined with a steep dose gradient outside the PTV. The cassette also demonstrated how the spatial dose distributions were drastically improved by the real-time adaptations with 1%/1-mm local gamma pass-rates that were increased from 8 to 79% (gating) and from 35 to 89% (MLC tracking). The cassette-determined beam-gating latency agreed within ≤ $\le$ 12 ms with the ground truth latency measurement. Film and PSD dose agreed well for most cases (differences relative to TPS dose < $<$ 4%), while film-PSD coregistration uncertainty caused relative differences of 5%-8%. Conclusions: This study demonstrates the excellent suitability of a new commercial hybrid film-scintillator cassette for simultaneous spatial, temporal, and motion-included dosimetry.

Dosimetric performance of a multi-point plastic scintillator dosimeter as a tool for real-time source tracking in high dose rate brachytherapy

Technical Note: A Novel Electromagnetic-Tracked Scintillation Dosimeter for Accurate In Vivo Dosimetry in HDR Brachytherapy

3D source tracking and error detection in HDR using two independent scintillator dosimetry systems

Seven-probe scintillator dosimeter for treatment verification in HDR-brachytherapy

Characterization of Plastic Scintillator Detector for In Vivo Dosimetry in Gynecologic Brachytherapy

Design and commissioning of a Silicon Photomultiplier-based dosimeter for Low Dose Rate (LDR) oncological brachytherapy

Preliminary Characterization of an Active CMOS Pad Detector for Tracking and Dosimetry in HDR Brachytherapy

Design and Characterization of a Novel Scintillator Array for In Vivo Monitoring During UHDR PBS Proton Therapy

Establishing a fingerprinting method for fast catheter identification in HDR brachytherapy in vivo dosimetry

Characterization of a novel time-resolved, real-time scintillation dosimetry system for ultra-high dose rate radiation therapy applications

From conception to clinical trial: IViST, the first multi-sensor-based platform for real-time In Vivo Source Tracking in HDR brachytherapy

Performance characterization of a novel hybrid dosimetry insert for simultaneous spatial, temporal, and motion-included dosimetry for MR-linac

In vivo dosimetry with an inorganic scintillation detector during multi-channel vaginal cylinder pulsed dose-rate brachytherapy: Dosimetry for pulsed dose-rate brachytherapy

Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy

Automated multi-parameter high-dose-rate brachytherapy quality assurance via radioluminescence imaging

Performance of the HYPERSCINT scintillation dosimetry research platform for the 1.5 T MR-linac

Quantitative real-time measurements of dose and dose rate in UHDR proton pencil beams via scintillation imaging system

Challenges for the Implementation of Primary Standard Dosimetry in Proton Minibeam Radiation Therapy

Cerenkov free micro-dosimetry in small-field radiation therapy technique

Quantitative, real‐time scintillation imaging for experimental comparison of different dose and dose rate estimations in UHDR proton pencil beams

Feasibility of determining external beam radiotherapy dose using LuSy dosimeter